The Kerala Ayurveda Vaidyasala Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-12-2024
- Paid Up Capital ₹ 0.50 M
as on 16-12-2024
- Company Age 78 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 0.15 M
as on 16-12-2024
About The Kerala Ayurveda Vaidyasala
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹0.15 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Madhavan Veetil, Kakkottakath Kunhi, Jayachandran Koroth, and Six other members serve as directors at the Company.
- CIN/LLPIN
U24233KL1946PLC001495
- Company No.
001495
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
28 Oct 1946
- Date of AGM
29 Nov 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kannur, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at The Kerala Ayurveda Vaidyasala?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhavan Veetil  | Managing Director | 01-Apr-1991 | Current |
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kakkottakath Kunhi | Director | 19-Feb-1985 | Current |
| Jayachandran Koroth | Director | 22-Dec-1993 | Current |
| Manheri Kutty | Whole-Time Director | 17-Jul-2002 | Current |
| Pillayadi Nambiar | Director | 03-Jun-1991 | Current |
| Pillayadi Surendran | Director | 17-Jul-2002 | Current |
| Pillayadi Vasudevan | Director | 30-Jun-2022 | Current |
Financial Performance of The Kerala Ayurveda Vaidyasala.
The Kerala Ayurveda Vaidyasala Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of The Kerala Ayurveda Vaidyasala?
In 2017, The Kerala Ayurveda Vaidyasala had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Catholic Syrian Bank Ltd. Creation Date: 11 Nov 1994 | ₹0.15 M | Satisfied |
How Many Employees Work at The Kerala Ayurveda Vaidyasala?
Unlock and access historical data on people associated with The Kerala Ayurveda Vaidyasala, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of The Kerala Ayurveda Vaidyasala, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped The Kerala Ayurveda Vaidyasala's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
